Abstract
Ephrin-As are repulsive axonal guidance cues that regulate retinotectal projection. EphA tyrosine kinases, which are the receptors of ephrin-As, activate signaling cascades leading to cytosckeleton reorganization. Here, we address the role of cyclin-dependent kinase (Cdk) 5 in Eph receptor signaling induced by ephrin-A5. Ephrin-A5 induced a cell morphological response in PC-3M cells that endogenously express Cdk5 and EphA2, a receptor for ephrin-A5. This response was augmented by the transfection of p35, which is a neuronal regulator of Cdk5. While the morphological response of native PC-3M cells was not affected by olomoucine, an inhibitor of Cdk, the response was inhibited in the p35-transfected cells. In retinal ganglion cells, either olomoucine at 20 microM or Y-27632 at 10 microM, an inhibitor of Rho-kinase/ROKalpha/ROCKII, showed maximum inhibitory effect against ephrin-A5 (10 microg/ml)-induced growth cone collapse. Combined application of olomoucine and Y-27632 further suppressed the ephrin-A5-induced response. Ephrin-A5 evoked phosphorylation of Cdk5 at Tyr15 and tau, a substrate of Cdk5 in retinal growth cones. Recombinant herpes simplex virus expressing Cdk5 mutant (kinase-negative or Tyr15 to Ala) showed a dominant-negative effect on the ephrin-A5-induced growth cone collapse. These findings demonstrate that both Cdk5 and the Rho kinase pathway independently contribute to the downstream of ephrin-A-induced signaling in retinal ganglion cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Cell Differentiation / drug effects
-
Cell Differentiation / physiology
-
Cell Line
-
Cell Size / drug effects
-
Cell Size / physiology
-
Cells, Cultured
-
Chick Embryo
-
Cyclin-Dependent Kinase 5
-
Cyclin-Dependent Kinases / antagonists & inhibitors
-
Cyclin-Dependent Kinases / genetics
-
Cyclin-Dependent Kinases / metabolism*
-
Enzyme Inhibitors / pharmacology
-
Ephrin-A5 / metabolism*
-
Ephrin-A5 / pharmacology
-
Growth Cones / drug effects
-
Growth Cones / metabolism*
-
Growth Cones / ultrastructure
-
Humans
-
Intracellular Signaling Peptides and Proteins
-
Mutation / genetics
-
Nerve Tissue Proteins / antagonists & inhibitors
-
Nerve Tissue Proteins / genetics
-
Nerve Tissue Proteins / metabolism
-
Phosphorylation / drug effects
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / metabolism*
-
Receptor, EphA2 / drug effects
-
Receptor, EphA2 / metabolism
-
Retina / cytology
-
Retina / embryology
-
Retina / metabolism
-
Retinal Ganglion Cells / cytology
-
Retinal Ganglion Cells / drug effects
-
Retinal Ganglion Cells / metabolism*
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
-
Superior Colliculi / cytology
-
Superior Colliculi / embryology
-
Superior Colliculi / metabolism
-
Visual Pathways / cytology
-
Visual Pathways / embryology
-
Visual Pathways / metabolism
-
rho-Associated Kinases
Substances
-
Enzyme Inhibitors
-
Ephrin-A5
-
Intracellular Signaling Peptides and Proteins
-
Nerve Tissue Proteins
-
neuronal Cdk5 activator (p25-p35)
-
Receptor, EphA2
-
Cyclin-Dependent Kinase 5
-
Protein Serine-Threonine Kinases
-
rho-Associated Kinases
-
CDK5 protein, human
-
Cyclin-Dependent Kinases